Introduction: Currently, there have been limited data on the presence of antiphospholipid antibodies (aPLs) in patients with uterine malignancies (UMs). Objectives: We aimed to determine whether ...

APLS board member and ALGOP chairman John Wahl ... Approve written selection criteria for minors that prevents the purchase or otherwise acquiring of any material advertised for consumers younger ...

APELLIS PHARMACEUTICALS INC (APLS) is a mid-cap growth stock in the ... the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are ...

In this issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Majdan et al 10 investigated the presence of criteria and noncriteria aPLs in patients with uterine malignancies. There are ...

Apellis Pharmaceuticals APLS provided third-quarter 2023 preliminary revenues guidance for its recently launched drug, Syfovre (pegcetacoplan injection), for the treatment of geographic atrophy ...